Clinical Trials | Pulmonary Medicine | Dartmouth-Hitchcock
Skip to main content
x
Dartmouth-Hitchcock logo
Summer Flowers In This Section

Clinical Trials

A clinical trial is a research study in which people can participate. The purpose of a clinical trial is to study the effectiveness of a treatment, medication, experimental drug, or device.

The following is a list of clinical trials with which the Pulmonary Department at Dartmouth-Hitchcock Medical Center is currently involved. Talk to your doctor to find out if a clinical trial is right for you.

Pulmonology Clinical Trials
A Double Blind, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Nintedanib over 52 Weeks in Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Safety, Tolerability, Biological Activity, and PK of ND-L02-s0201 In Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 3, Open-Label, Rollover Study to Evaluate the Safety and Efficacy of Long-Term Treatment with XV-661 in Combination with Ivacaftor in Subjects Aged 12 Years and Older with Cystic Fibrosis, homozygous or Heterozygous for the F508del-Cftr Mutation
A Phase 3, Open-label, Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Tezacaftor in Combination With Ivacaftor in Subjects With Cystic Fibrosis Aged 6 Years and Older, Homozygous or Heterozygous for the F508del-CFTR Mutation
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)
A Randomized, Double-Blind, Placebo-Controlled Study To Evaluate the Efficacy and Safety of BG00011 in Patients With Idiopathic Pulmonary Fibrosis
A Subject-, Investigator-, and Sponsor-blinded, Randomized, Placebo-controlled, Multicenter Study to Investigate Efficacy, Safety, and Tolerability of VAY736 in Patients With Idiopathic Pulmonary Fibrosis
Alveolar Macrophage and Peripheral Blood Monocyte Dysfunction in Cystic Fibrosis
Biofilm Formation, Antibiotic Resistance Phosphatidylcholine Utilization By Pseudomonas In Cf Sputum
Cystic Fibrosis Foundation Patient Registry
Evaluation of Autoimmunity in Patients with Non-CF Bronchiectasis
Host Pathogen Interactions In Gi Epithelium In Cystic Fibrosis
IGF-1 and IGFBP3 as markers of exacerbation in Cystic Fibrosis
Longitudinal Evaluation of Aspergillus fumigatus in patients with CF
Serial Assessment of Volatile Compounds in the Breath of Patients with Cystic Fibrosis (CF)
Standardized Treatment of Pulmonary Exacerbations II
Study of Clinical Efficacy of Antimicrobial Therapy Strategy Using Pragmatic Design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF)
The CHEC-SC Cohort Study: CHaractErizing CFTR Modulated Changes in Sweat Chloride and their Association with Clinical Outcomes
The Effects Of Systemic Anti-Pseudomonal Therapy On Fungal Load In Cystic Fibrosis
Contact Us

0